Breaks Categories: News

TuesdayJan 16, 2024 2:40 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as the completion of a phase 2 clinical trial and the launch of two new preclinical programs targeting the treatment of Alzheimer’s disease and age-related macular degeneration (‘AMD’),” said Eric A. Adams, InMed president and CEO.…

Continue Reading

TuesdayJan 09, 2024 1:19 pm

CannabisNewsBreaks – Branded Legacy Inc. (BLEG) Acquires All In Extracts LLC

Branded Legacy (OTC: BLEG), (soon to be known as Royal Enterprises Inc.), a burgeoning company in the pharmaceutical biotechnology sector, today announced its strategic acquisition of All In Extracts, a pioneering entity focused on medicinal ethnobotany. The milestone deal amplifies Branded Legacy’s focus on innovation, expansion and collaborative growth within the biotech community. “As soon as I met with the All In team, I knew something great was in the making,” said Branded Legacy CEO David Oswald. “It is a rare enough thing to find a company motivated primarily by the positive impact they can make on society. We are…

Continue Reading

TuesdayJan 09, 2024 12:14 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Featured in Bell2Bell Podcast

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a global infrastructure and holding company in the cannabis industry, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Jose Gabriel Diaz, CEO of Software Effective Solutions, joined the program to provide an introduction to MedCana and its business model. “We are a U.S.-based holding company focused on developing infrastructure and cannabis companies around the world. Right now, the focus is primarily on markets outside of the U.S. that have already fully legalized pharmaceutical (and possibly some…

Continue Reading

FridayJan 05, 2024 1:20 pm

CannabisNewsBreaks – IBN, CannabisNewsWire Re-Engaged for NECANN’s 2024 Event Lineup

IBN, a multifaceted financial news and publishing company, today announced its expanded collaboration with NECANN, which specializes in orchestrating conventions that focus on the development and expansion of cannabis markets. Under the agreement, IBN’s CannabisNewsWire will continue to serve as the official newswire for the organization’s annual conference lineup. As part of the collaboration, IBN will amplify its support through its syndication network, providing comprehensive coverage for NECANN events. In collaboration with its network of 60+ online brands such as CannabisNewsWire and CannabisNewsWatch, IBN will deploy an extensive range of corporate-communications solutions to enhance visibility and recognition of conference participants…

Continue Reading

ThursdayJan 04, 2024 2:25 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of Rybelsus(R)-Branded GLP-1 Drug Semaglutide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive final results from its recently completed human Pilot Study #1 evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide available commercially in the branded product Rybelsus(R). According to the announcement, the study was performed by a prominent university research center comparing a single 7 mg semaglutide dose of a Rybelsus tablet (“control”) to a matching dose from Rybelsus that had been compound formulated in capsule form using DehydraTECH processing technology enhancements (“DehydraTECH GLP-1”). In general, the DehydraTECH processing enabled improvements…

Continue Reading

FridayDec 22, 2023 2:11 pm

CannabisNewsBreaks – BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) Closes US$1.5M Registered Direct Offering

BYND Cannasoft (NASDAQ: BCAN) (CSE: BYND), an Israeli-based integrated software and cannabis company, has announced the closing of the previously disclosed registered direct offering with an institutional investor of approximately $1.5 million common shares and investor warrants at a price of $0.52 per common unit. The company secured approximately $1.5 million in aggregate gross proceeds and expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. The transaction closed on Dec. 21, 2023. Aegis Capital Corp. is acting as exclusive placement agent for the offering. Louis A. Brilleman, P.C.…

Continue Reading

ThursdayDec 21, 2023 4:59 pm

CannabisNewsBreaks – WEED Inc.’s (BUDZ) HEMP BioSciences Inc. Receives Full Suite of Industrial Hemp Licenses from State of Arizona

WEED (OTCQB: BUDZ) is a global cannabis and hemp bioresearch company based in the U.S. focused on the development and application of cannabis–derived compounds for the treatment of human and animal diseases. The company, together with its HEMP BioSciences Inc. (“HEMP”) division, today announced its intention to expand into consumer packaged goods utilizing its rare Landrace strains including Original Panama Red, Acapulco Gold, Red Bud Colombian and Santa Marta Gold. “HEMP has been issued all required licenses for Industrial HEMP; Growing, Nursery, Harvester, Transporter and Processor licenses under Title 3-Chapter 2-Article 4.1 of The Arizona Department of Agriculture,” said Nicole…

Continue Reading

WednesdayDec 20, 2023 10:32 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors During 2023 Annual General Meeting

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2023 annual general meeting. According to the report, during the meeting, which was held on Dec. 19, 2023, all matters considered by shareholders were approved; agenda items were sent to shareholders in a notice of meeting and management information communication that was released on Oct. 27, 2023. In addition, shareholders approved the election of five directors, including Eric A. Adams, Janet Grove, Andrew Hull, Nicole Lemerond and Bryan Baldasare; directors will hold their…

Continue Reading

TuesdayDec 12, 2023 1:55 pm

CannabisNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Creates New Subsidiary, Announces Application of New Technology

Astrotech (NASDAQ: ASTC), an innovative science and technology company, has formed a new wholly owned subsidiary: Pro-Control Inc. According to the announcement, Pro-Control is unveiling its proprietary Pro-Control Maximum Value Process(TM) (Pro-Control MVP(TM) and the Pro-Control-1000(TM) mass spectrometer. The spectrometer has been designed to work within a chemical factory analyzing real-time samples while achieving optimized yields, quality and profits. It tests, measures and increases potency, purity and weight yields. Astrotech has entered into an exclusive license with Pro-Control to use the ATi mass spectrometer technology for chemical manufacturing process control applications. The Pro-Control MVP rapid test can take up to 20 tests…

Continue Reading

TuesdayDec 12, 2023 1:40 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Engages IBN for Corporate Communications Expertise

Software Effective Solutions (OTC: SFWJ), a global infrastructure and holding company in the cannabis industry, today announced that it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. MedCana’s current portfolio includes five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations and an irrigation and greenhouse technology company. The company’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals around the world. As part of…

Continue Reading